Back to Search
Start Over
Intravenous bevacizumab as a novel treatment for refractory left ventricular assist device-related gastrointestinal bleeding.
- Source :
-
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation [J Heart Lung Transplant] 2020 May; Vol. 39 (5), pp. 492-495. Date of Electronic Publication: 2020 Feb 24. - Publication Year :
- 2020
- Subjects :
- Administration, Intravenous
Aged
Angiogenesis Inhibitors administration & dosage
Female
Follow-Up Studies
Gastrointestinal Hemorrhage etiology
Humans
Male
Retrospective Studies
Treatment Outcome
Bevacizumab administration & dosage
Gastrointestinal Hemorrhage drug therapy
Heart Failure therapy
Heart-Assist Devices adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1557-3117
- Volume :
- 39
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
- Publication Type :
- Editorial & Opinion
- Accession number :
- 32173217
- Full Text :
- https://doi.org/10.1016/j.healun.2020.02.012